Cutaneous B-Cell Lymphoma


Cutaneous B-cell lymphoma is not a single disease, but rather a family of neoplastic processes characterized by a proliferation of malignant B lymphocytes. These lymphomas may arise de novo on the skin (primary cutaneous B cell lymphoma) or spread to the skin as part of a systemic disease (secondary cutaneous B-cell lymphoma). It is not possible to make this distinction based purely on histologic findings, and a systemic work-up is required in all of these patients in order to determine the extent of disease. The prognosis is greatly altered depending upon this extent. As subtypes of lymphoma correlate with clinical correlation, histologic findings, and prognosis, several of the most prevalent subtypes will be described individually.


Marginal Zone Lymphoma Reactive Germinal Center Light Chain Restriction Intravascular Lymphoma Neoplastic Follicle 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cerroni L, Signoretti S, Hofler G, Annessi G, Putz B, Lackinger E, Metze D, Giannetti A, Kerl H. Primary cutaneous marginal zone B-cell lymphoma: A recently described entity of low-grade malignant cutaneous B-cell lymphoma. Am J Surg Pathol 1997; 21: 1307–1315.PubMedCrossRefGoogle Scholar
  2. 2.
    Tomaszewski M-M, Abbondanzo SL, Lupton GL. Extranodal marginal zone B-cell lymphoma of the skin: A morphologic and immunophenotypic study of 11 cases. Am J Dermatopathol 2000; 22: 205–211.PubMedCrossRefGoogle Scholar
  3. 3.
    Cerroni L, Kerl H. Cutaneous follicle center cell lymphoma, follicular type. Am J Dermatopathol 2001; 23: 370–373.PubMedCrossRefGoogle Scholar
  4. 4.
    Cerroni L, Volkenandy M, Rieger E, Soyer HP, Kerl H. bcl-2 protein expression and correlation with the interchromosomal 14:18 translocation in cutaneous lymphomas and pseudolymphomas. J Invest Dermatol 1994; 102: 231–235.PubMedCrossRefGoogle Scholar
  5. 5.
    Rijlaarsdam JU, Toonstra J, Meijer OWM, Noordijk EM, Willemze R. Treatment of primary cutaneous B-cell lymphomas of follicular center cell origin. J Clin Oncol 1996; 14: 549–555.PubMedGoogle Scholar
  6. 6.
    Vermeer MH, Geelen FAMJ, van Haselen CW, van Voorst Vader PC, Geerts M-L, van Vloten WA, Willemze R (for the Dutch Lymphoma Working Group). Primary cutaneous large B-cell lymphomas of the legs. Arch Dermatol 1996; 132: 1304–1308.PubMedCrossRefGoogle Scholar
  7. 7.
    Goodlad JR, Krajewski AS, Batstone PJ, McKy P, White JM, Benton EC, Kavanagh GM, Lucraft HH (on behalf of the Scotland and Newcastle Lymphoma Group). Primary cutaneous diffuse large B-cell lymphoma: Prognostic significance of clinicopathological subtypes. Am J Surg Pathol 2003; 27: 1538–1545.PubMedCrossRefGoogle Scholar
  8. 8.
    Bhawan J, Wolff SM, Ucci AA, Bhan AK. Malignant lymphoma and malignant angioendotheliomatosis: One disease. Cancer 1985; 55: 570–576.PubMedCrossRefGoogle Scholar
  9. 9.
    Wick MR, Mills SE, Sheithauer BW, Cooper PH, Davitz MA, Parkinson K. Reassessment of malignant “angioendotheliomatosis”: Evidence in favor of its reclassification as “intravascular lymphomatosis.” Am J Surg Pathol 1986; 10: 112–123.PubMedCrossRefGoogle Scholar
  10. 10.
    Sangueza O, Hyder DM, Sangueza P. Intravascular lymphomatosis: Report of an unusual case with T cell phenotype occurring in an adolescent male. J Cutan Pathol 1992; 19: 226–231.PubMedCrossRefGoogle Scholar
  11. 11.
    Sepp N, Schuler G, Romani N, Geissler D, Gattringer C, Burg G, Bartram CR, Fritsch P. “Intravascular lymphomatosis” (angioendotheliomatosis): Evidence for a T-cell origin in two cases. Hum Pathol 1990: 20: 1051–1058.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Personalised recommendations